Enliven Therapeutics, Inc. (ELVN)
37.00
+0.89
(+2.46%)
USD |
NASDAQ |
Jun 10, 16:00
38.29
+1.29
(+3.49%)
After-Hours: 20:00
Enliven Therapeutics Price : 37.00 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 35.71 | 37.41 | 35.71 | 37.00 | 1.272M |
| Jun 09, 2026 | 34.62 | 36.22 | 34.20 | 36.11 | 1.835M |
| Jun 08, 2026 | 35.45 | 35.79 | 33.45 | 33.63 | 834212.0 |
| Jun 05, 2026 | 35.44 | 36.07 | 33.68 | 34.71 | 1.076M |
| Jun 04, 2026 | 36.00 | 38.01 | 35.46 | 35.49 | 1.127M |
| Jun 03, 2026 | 35.40 | 36.26 | 34.90 | 36.03 | 696245.0 |
| Jun 02, 2026 | 37.30 | 37.53 | 35.42 | 35.52 | 1.811M |
| Jun 01, 2026 | 39.43 | 39.66 | 36.85 | 37.51 | 694833.0 |
| May 29, 2026 | 40.65 | 40.94 | 39.02 | 39.57 | 747916.0 |
| May 28, 2026 | 41.48 | 41.50 | 40.38 | 40.65 | 303294.0 |
| May 27, 2026 | 42.67 | 42.99 | 41.31 | 41.41 | 519002.0 |
| May 26, 2026 | 42.04 | 42.60 | 40.73 | 42.53 | 538925.0 |
| May 22, 2026 | 42.81 | 43.05 | 41.43 | 41.54 | 632207.0 |
| May 21, 2026 | 41.59 | 42.97 | 40.80 | 42.25 | 918334.0 |
| May 20, 2026 | 40.56 | 42.39 | 40.30 | 41.86 | 638455.0 |
| May 19, 2026 | 39.55 | 40.26 | 38.58 | 40.17 | 636114.0 |
| May 18, 2026 | 41.34 | 41.78 | 38.78 | 39.63 | 510761.0 |
| May 15, 2026 | 42.21 | 42.95 | 41.07 | 41.34 | 500943.0 |
| May 14, 2026 | 43.61 | 43.97 | 42.03 | 43.08 | 562708.0 |
| May 13, 2026 | 42.24 | 45.14 | 40.92 | 43.56 | 1.213M |
| May 12, 2026 | 40.65 | 43.28 | 39.78 | 42.30 | 1.137M |
| May 11, 2026 | 41.33 | 42.00 | 39.34 | 39.59 | 705307.0 |
| May 08, 2026 | 41.56 | 42.90 | 40.02 | 40.75 | 606599.0 |
| May 07, 2026 | 41.08 | 41.32 | 39.54 | 40.29 | 461013.0 |
| May 06, 2026 | 41.98 | 42.33 | 40.76 | 41.20 | 370282.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.00 |
| CNBX Pharmaceuticals, Inc. | 0.0002 |
| GB Sciences, Inc. | 0.0004 |
| Arvinas, Inc. | 6.98 |
| Fulcrum Therapeutics, Inc. | 3.51 |
Price Related Metrics
| Price to Book Value | 4.969 |
| Earnings Yield | -4.50% |
| Market Cap | 2.253B |